A retrospective study conducted in France from 1996 to 2013 found that a significant proportion of PEL patients had experienced severe immune deficiency, with 65% having a prior history of AIDS-defining conditions, and 25% still exhibiting CD4 counts below 200 cells/μL at PEL diagnosis [6]. The gene discussed is CD4; the disease is primary effusion lymphoma.